Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun-Wei Lin

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|January 23, 2014
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cellsJen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Toxicology Letters|May 15, 2012
Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell linesChien-Hsing Lu, Shin-Chang Lin, Shu-Yi Yang, et al.
Basic & Clinical Pharmacology & Toxicology|June 6, 2015
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer CellsJen-Chung Ko, Jhan-Jhang Syu, Jyh-Cheng Chen, et al.
Pharmacology|October 21, 2019
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ting-Chuan Yen, et al.
Molecular Cancer Research : MCR|August 13, 2009
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cellsJen-Chung Ko, Shih-Ci Ciou, Jhih-Yuan Jhan, et al.
Experimental Cell Research|June 10, 2009
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivationRuey-Shyang Chen, Jhih-Yuan Jhan, Ying-Jhen Su, et al.
Toxicology|February 24, 2019
Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Tzu-Ying Chen, et al.
Experimental Cell Research|April 30, 2017
Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cellsChun-Liang Tung, Jyh-Cheng Chen, Chia-Hung Wu, et al.
Experimental Cell Research|February 18, 2014
Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cellsChun-Liang Tung, Hsien-Chun Chiu, Yi-Jun Jian, et al.
Regulatory Toxicology and Pharmacology : RTP|October 4, 2016
Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cellsKai-Sheng Liao, Chia-Li Wei, Jyh-Cheng Chen, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|January 23, 2014
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cellsJen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Toxicology Letters|May 15, 2012
Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell linesChien-Hsing Lu, Shin-Chang Lin, Shu-Yi Yang, et al.
Basic & Clinical Pharmacology & Toxicology|June 6, 2015
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer CellsJen-Chung Ko, Jhan-Jhang Syu, Jyh-Cheng Chen, et al.
Pharmacology|October 21, 2019
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ting-Chuan Yen, et al.
Molecular Cancer Research : MCR|August 13, 2009
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cellsJen-Chung Ko, Shih-Ci Ciou, Jhih-Yuan Jhan, et al.
Experimental Cell Research|June 10, 2009
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivationRuey-Shyang Chen, Jhih-Yuan Jhan, Ying-Jhen Su, et al.
Toxicology|February 24, 2019
Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Tzu-Ying Chen, et al.
Experimental Cell Research|April 30, 2017
Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cellsChun-Liang Tung, Jyh-Cheng Chen, Chia-Hung Wu, et al.
Experimental Cell Research|February 18, 2014
Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cellsChun-Liang Tung, Hsien-Chun Chiu, Yi-Jun Jian, et al.
Regulatory Toxicology and Pharmacology : RTP|October 4, 2016
Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cellsKai-Sheng Liao, Chia-Li Wei, Jyh-Cheng Chen, et al.
Pageof 6